Petros Pharmaceuticals, Inc. Current Liabilities
Petros Pharmaceuticals, Inc. (PTPI) had Current Liabilities of $2.84 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $2.84M.
- 2026-03-31: Liabilities, Current $2.62M.
- 2025-12-31: Liabilities, Current $2.29M.
- 2025-09-30: Liabilities, Current $2.77M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $2.84M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $2.62M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $2.29M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $2.77M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.95M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $27.13M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $18.03M 10-K · filed 2026-04-15 |
| 2024-09-30 | $12.56M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $9.98M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $11.22M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $10.77M 10-K · filed 2025-03-31 |
| 2023-09-30 | $8.08M 10-Q · filed 2023-11-15 |
| 2023-06-30 | $7.97M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $6.89M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $7.07M 10-K · filed 2024-04-01 |
| 2022-09-30 | $7.94M 10-Q/A · filed 2022-11-15 |
| 2022-06-30 | $7.38M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $10.29M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $30.98M 10-K · filed 2023-03-31 |
| 2021-09-30 | $33.50M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $34.49M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $40.22M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $41.89M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |